Menstrual disturbances in puberty

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 24, Issue 2, 2010, Pages 157-171

  Deligeoroglou, Efthimios ^a   Tsimaris, Pandelis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

amenorrhoea; delayed Puberty; dysfunctional uterine bleeding; dysmenorrhoea; hypergonadotrophic hypogonadism; hyperprolactinaemia; hypogonadotrophic hypogonadism; hypothalamic amenorrhoea; Menstrual Disorders; precocious Puberty; premature ovarian failure

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMOCRIPTINE; CABERGOLINE; CONJUGATED ESTROGEN; ESTROGEN; GLYCERYL TRINITRATE; GONADORELIN ANTAGONIST; IRON; LEVONORGESTREL; LIPOXYGENASE INHIBITOR; LISURIDE; MAGNESIUM; MEDROXYPROGESTERONE ACETATE; NEUROLEPTIC AGENT; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PERGOLIDE; PLACEBO; PROGESTERONE; QUINAGOLIDE; THIAMINE; TRANEXAMIC ACID; UNINDEXED DRUG; VERAPAMIL;

AMENORRHEA; CLINICAL TRIAL; DELAYED PUBERTY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DYSMENORRHEA; GONADOTROPIN RELEASE; GYNECOLOGIC SURGERY; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; HYPERGONADOTROPIC HYPOGONADISM; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS DISEASE; IRON DEFICIENCY ANEMIA; LEG CRAMP; LOADING DRUG DOSE; LOW DRUG DOSE; MENARCHE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; METRORRHAGIA; NAUSEA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PATIENT COUNSELING; PRECOCIOUS PUBERTY; PREMATURE OVARIAN FAILURE; PRIMARY AMENORRHEA; PRIORITY JOURNAL; PUBERTY; REVIEW; RISK ASSESSMENT; SECONDARY AMENORRHEA; SEXUAL DEVELOPMENT; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; CHILD; FEMALE; GONADAL DISORDERS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENSTRUATION DISTURBANCES; PITUITARY DISEASES; PUBERTY;

EID: 77949262953     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2009.11.001     Document Type: Review

References (43)

1. Diaz A., Laufer M.R., Breech L.L., American Academy of Pediatrics Committee on Adolescence, and American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 118 (2006) 2245-2250
2. Ibáñez L., Potau N., Zampolli M., et al. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 82 (1997) 2283-2288
3. Hickey M., and Balen A. Menstrual disorders in adolescence: investigation and management. Hum Reprod Update 9 (2003) 493-504
4. Mann D.R., and Plant T.M. Leptin and pubertal development. Semin Reprod Med 20 (2002) 93-102
5. Clément K., Vaisse C., Lahlou N., et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998) 398-401
6. Deligeoroglou E., Tsimaris P., Deliveliotou A., et al. Menstrual disorders during adolescence. Pediatr Endocrinol Rev 3 Suppl. 1 (2006) 150-159
7. World Health Organization Task Force on Adolescent Reproductive Health. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. J Adolesc Health Care 7 (1986) 236-244
8. Treloar A.E., Boynton R.E., Behn B.G., et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12 (1967) 77-126
9. Vollman R.F. The menstrual cycle. Major Probl Obstet Gynecol 7 (1977) 1-193
10. Herman-Giddens M.E., Slora E.J., Wasserman R.C., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 99 (1997) 505-512
11. Root A.W. Precocious puberty. Pediatr Rev. 21 (2000) 10-19
12. Ibáñez L., Potau N., Dunger D., et al. Precocious pubarche in girls and the development of androgen excess. J Pediatr Endocrinol Metab 13 Suppl. 5 (2000) 1261-1263
13. Pathomvanich A., Merke D.P., and Chrousos G.P. Early puberty: a cautionary tale. Pediatrics 105 (2000) 115-116
14. Léger J., Reynaud R., and Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?. J Pediatr 137 (2000) 819-825
15. The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 90 Suppl. 3 (2008) S219-S225
16. Slap G.B. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol 17 (2003) 75-92
17. Frisch R.E., and McArthur J.W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 185 (1974) 949-951
18. Warren M.P., and Goodman L.R. Exercise-induced endocrine pathologies. J Endocrinol Invest 26 (2003) 873-888
19. Meczekalski B., Podfigurna-Stopa A., Warenik-Szymankiewicz A., et al. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 24 (2008) 4-11
20. Vescovi J.D., Jamal S.A., and De Souza M.J. Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature. Osteoporos Int 19 (2008) 465-478
21. Jayasinghe Y., Grover S.R., and Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG 115 (2008) 304-315
22. Wallaschofski H., Kobsar A., Sokolova O., et al. Co-activation of platelets by prolactin or leptin-pathophysiological findings and clinical implications. Horm Metab Res 36 (2004) 1-6
23. Patel S.S., and Bamigboye V. Hyperprolactinaemia. J Obstet Gynaecol 27 (2007) 455-459
24. Vallette-Kasic S., Morange-Ramos I., Selim A., et al. Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 87 (2002) 581-588
25. Miller K.K. Management of hyperprolactinemia in patients receiving antipsychotics. CNS Spectr 9 Suppl. 7 (2004) 28-32
26. Nippita T.A., and Baber R.J. Premature ovarian failure: a review. Climacteric 10 1 (2007) 11-22
27. Allingham-Hawkins D.J., Babul-Hirji R., Chitayat D., et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 83 (1999) 322-325
28. Nelson L.M. Primary ovarian insufficiency. N Engl J Med 360 (2009) 606-614
29. Kalantaridou S.N., and Nelson L.M. Premature ovarian failure is not premature menopause. Ann N Y Acad Sci. 900 (2000) 393-402
30. Demeestere I., Simon P., Englert Y., et al. Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. Reprod Biomed Online 7 (2003) 572-579
31. Fraser I.S., and Sungurtekin U. Defining menstrual disturbances. In: Maclean A., and O'Brien P.M.S. (Eds). Study group on menstrual disorders (2000), Royal College of Obstetricians and Gynecologist 141-152
32. Minjarez D.A., and Bradshaw K.D. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am 27 (2000) 63-78
33. Claessens E.A., and Cowell C.A. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 28 (1981) 369-378
34. Kouides P.A. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 14 (2000) 381-399
35. Bevan J.A., Maloney K.W., Hillery C.A., et al. Bleeding disorders: A common cause of menorrhagia in adolescents. J Pediatr 138 (2001) 856-861
36. Kadir R.A., and Aledort L.M. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol 22 Suppl. 1 (2000) 12-16
37. Mammen E.F. Haemostatic dysfunction related to liver diseases and liver transplantation. In: Beutler E., Lichtman M.A., Coller B.S., et al. (Eds). Williams hematology. 6th ed. (2001), McGraw-Hill Professional, New York 1673-1676
38. Deligeoroglou E. Dysfunctional uterine bleeding. Ann N Y Acad Sci 816 (1997) 158-164
39. Kriplani A., Kulshrestha V., Agarwal N., et al. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 26 (2006) 673-678
40. Andersch B., and Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 144 (1982) 655-660
41. Klein J.R., and Litt I.F. Epidemiology of adolescent dysmenorrhea. Pediatrics 68 (1981) 661-664
42. Deligeoroglou E. Dysmenorrhea. Ann N Y Acad Sci 900 (2000) 237-244
43. Creatsas G., Deligeoroglou E., Zachari A., et al. Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur J Obstet Gynecol Reprod Biol 36 (1990) 292-298